As of August 28, 2026, Rhythm Pharmaceuticals, Inc. (RYTM) has a DilutionWatch DilutionScore of 14/100, rated LOW dilution risk. Rhythm Pharmaceuticals, Inc. has a market capitalization of $6.05B, 68.85M shares outstanding, 288 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for RYTM.
Market Data
Market Cap$6.05B
Shares Outstanding68.85M
Float55.70M
Cash$330.90M
Debt$106.10M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 15.4% shares (2026Q1 vs prior)
288 institutional holders · 86.26M shares
#1
RA CAPITAL MANAGEMENT, L.P.
6.67M shares
#2
BlackRock, Inc.
6.24M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
5.94M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest9.44M
Days to Cover16.2
% of Float16.9%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2025-12-31
Form 4
INSIDER TRANSACTION
2026-08-17
Form 4
INSIDER TRANSACTION
2026-08-17
Form 4
INSIDER TRANSACTION
2026-08-13
Form 4
INSIDER TRANSACTION
2026-08-13
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual RYTM Dilution Snapshot
Rhythm Pharmaceuticals, Inc. (RYTM) has a DilutionScore of 14/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for RYTM: Form 4 on 2026-08-17; Form 4 on 2026-08-17; Form 4 on 2026-08-13.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track RYTM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RYTM — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for RYTM
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.